Glioblastoma multiforme (GBM), the most common type of malignant brain tumor, has a very high mortality rate, due in part to ...

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

Folded Hills Winery, Ranch & Farmstead co-founders Kim and Andy Busch announce the official launch of Grapes for Glioblastoma ...

Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

Brain cancer breakthrough as new study finds cell therapy could target deadly glioblastoma - Patients diagnosed with ...

Researchers have identified a critical biological difference in how glioblastoma develops in male and female laboratory models, pinpointing an immune pathway that fuels tumor growth only in females.

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients survive ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. While rare, malignant brain tumors often have poor outcomes Nearly half of all malignant ...

It’s a strange sensation sitting at the keyboard and writing this sentence: I have a deep and personal connection to the President of the United states. But I do. And no, I’m not talking politics. Joe ...